ICPO Foundation Presents its first Maurits W. Geerlings Actinium-225 Next Generation Award to Dr. Madhav Yadav from AIIMS, India at the 6th Theranostics World Congress (TWC)
A novel prostate cancer treatment-;225Ac-PSMA-617 radioligand therapy-;has been shown to increase the progression free survival (PFS) and overall survival (OS) of metastatic castration-resistant prostate cancer (mCRPC) patients, according to research published by The Journal of Nuclear Medicine.
2022-01 - The Gender Commission has failed women wits.ac.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wits.ac.za Daily Mail and Mail on Sunday newspapers.